Joshua Schafer, CCO & EVP, Business Development at ZEVRA THERAPEUTICS, INC. (ZVRA), bought 500 shares at $5.13 ($3K) on 2023-09-05, disclosed to the SEC on 2023-09-06.
Open-market purchase of $3k ZVRA by CCO & EVP, Business Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| ZVRA | SELL | 2025-02-14 | $83K | — | Filing → |
| ZVRA | BUY | 2023-06-30 | $5K | — | Filing → |
| ZVRA | BUY | 2023-03-15 | $9K | — | Filing → |